The health care costs of cervical human papillomavirus–related disease
- 1 July 2004
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 191 (1) , 114-120
- https://doi.org/10.1016/j.ajog.2004.01.042
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The psychological impact of abnormal cytology and colposcopyBJOG: An International Journal of Obstetrics and Gynaecology, 2002
- Technologic Advances for Evaluation of Cervical Cytology: Is Newer Better?Obstetrical & Gynecological Survey, 2001
- Improving Adherence to Abnormal Pap Smear Follow-UpJournal of Obstetric, Gynecologic & Neonatal Nursing, 2001
- Frequency of cervical smear abnormalities within 3 years of normal cytologyObstetrics & Gynecology, 2000
- Cost-effectiveness of the Conventional Papanicolaou Test With a New Adjunct to Cytological Screening for Squamous Cell Carcinoma of the Uterine Cervix and Its PrecursorsArchives of Family Medicine, 2000
- Estimates of the Incidence and Prevalence of Sexually Transmitted Diseases in the United StatesSexually Transmitted Diseases, 1999
- The Association Between Health Care Coverage and the Use of Cancer Screening TestsMedical Care, 1998
- Cost-Effectiveness Analysis of Diagnosis and Management of Cervical Squamous Intraepithelial LesionsObstetrics & Gynecology, 1998
- Cost-Effective Policies for Cervical Cancer ScreeningPharmacoEconomics, 1996
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995